Literature DB >> 12644866

Development-associated myristoylated alanine-rich C kinase substrate phosphorylation in rat brain.

Hideo Hamada1, Yun-Ling Zhang, Akiko Kawai, Fang Li, Yasuhide Hibino, Yutaka Hirashima, Masanori Kurimoto, Nakamasa Hayashi, Ichiro Kato, Shunro Endo, Koichi Hiraga.   

Abstract

OBJECT: In neuronal cells, myristoylated alanine-rich C kinase substrate (MARCKS), localized to particular areas of the synaptic membrane, is active during brain development. The destination of phosphorylated MARCKS is thought to be the cytoplasm where it is probably inactive. We compared MARCKS phosphorylation in the brains of embryonic, perinatal, and adult rats to determine its possible involvement in neurogenesis.
METHODS: We prepared crude and partially purified extracts from various brain regions of rats aged between embryonic day 14 (E14) and 7 weeks after birth and assayed them for MARCKS phosphorylation by immunochemical methods. The isotypes of protein kinase C (PKC) were immunochemically identified in crude brain extracts from embryonic and postnatal rats. Despite negligible MARCKS phosphorylation, E16 brain extracts contained both MARCKS and PKCgamma, delta, epsilon, and lambda. MARCKS and polypeptides were clearly phosphorylated (49 and 45 kDa, respectively) in brain extracts purified on a DE52 column. Embryonic brain extracts manifested a high-molecular-weight activity capable of suppressing polypeptide phosphorylation. This activity was markedly decreased on the day of birth and almost undetectable in the brains of 9-day-old rats.
CONCLUSIONS: The embryonic rat brain appears to contain a protein(s) that suppresses the phosphorylation of other proteins including MARCKS. We posit that this inhibitory activity represents a factor(s) that plays a role in the regulation of neurogenesis beginning on the day on which MARCKS appears in the embryonic brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644866     DOI: 10.1007/s00381-002-0713-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  23 in total

Review 1.  The MARCKS brothers: a family of protein kinase C substrates.

Authors:  A Aderem
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

Review 2.  Cell lineage and cell migration in the developing cerebral cortex.

Authors:  C Walsh; C L Cepko
Journal:  Experientia       Date:  1990-09-15

Review 3.  Neural stem and progenitor cells: a strategy for gene therapy and brain repair.

Authors:  D W Pincus; R R Goodman; R A Fraser; M Nedergaard; S A Goldman
Journal:  Neurosurgery       Date:  1998-04       Impact factor: 4.654

4.  Neural tube defects and abnormal brain development in F52-deficient mice.

Authors:  M Wu; D F Chen; T Sasaoka; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) by proline-directed protein kinases and its dephosphorylation.

Authors:  H Yamamoto; F Arakane; T Ono; K Tashima; E Okumura; K Yamada; S Hisanaga; K Fukunaga; T Kishimoto; E Miyamoto
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

6.  The 87-kDa protein, a major specific substrate for protein kinase C: purification from bovine brain and characterization.

Authors:  K A Albert; A C Nairn; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  p42 MAPK phosphorylates 80 kDa MARCKS at Ser-113.

Authors:  D C Schönwasser; R H Palmer; T Herget; P J Parker
Journal:  FEBS Lett       Date:  1996-10-14       Impact factor: 4.124

8.  Selective activation of phospholipase C gamma1 and distinct protein kinase C subspecies in intracellular signaling by hepatocyte growth factor/scatter factor in primary cultured rat neocortical cells.

Authors:  M Machide; K Kamitori; Y Nakamura; S Kohsaka
Journal:  J Neurochem       Date:  1998-08       Impact factor: 5.372

9.  MARCKS deficiency in mice leads to abnormal brain development and perinatal death.

Authors:  D J Stumpo; C B Bock; J S Tuttle; P J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A.

Authors:  K Seki; H C Chen; K P Huang
Journal:  Arch Biochem Biophys       Date:  1995-02-01       Impact factor: 4.013

View more
  6 in total

1.  Two myristoylated alanine-rich C-kinase substrate (MARCKS) paralogs are required for normal development in zebrafish.

Authors:  Laura E Ott; Zachary T McDowell; Poem M Turner; J McHugh Law; Kenneth B Adler; Jeffrey A Yoder; Samuel L Jones
Journal:  Anat Rec (Hoboken)       Date:  2011-08-01       Impact factor: 2.064

2.  Calpain and MARCKS protein regulation of airway mucin secretion.

Authors:  W Randall Lampe; Joungjoa Park; Shijing Fang; Anne L Crews; Kenneth B Adler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-16       Impact factor: 3.410

3.  Regulation of protein kinase C isozymes during early postnatal hippocampal development.

Authors:  Sudarshana Purkayastha; Suraj Shawn Fernando; Souleymane Diallo; Leah Cohen; Buddima Ranasinghe; Kelly Levano; Probal Banerjee
Journal:  Brain Res       Date:  2009-07-08       Impact factor: 3.252

4.  Brain region-specific decrease in the activity and expression of protein kinase A in the frontal cortex of regressive autism.

Authors:  Lina Ji; Ved Chauhan; Michael J Flory; Abha Chauhan
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

5.  Reduced activity of protein kinase C in the frontal cortex of subjects with regressive autism: relationship with developmental abnormalities.

Authors:  Lina Ji; Abha Chauhan; Ved Chauhan
Journal:  Int J Biol Sci       Date:  2012-08-30       Impact factor: 6.580

6.  A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts.

Authors:  Andrea Toledo; Flavio R Zolessi; Cristina Arruti
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.